Form 4: Electromed CFO Boosts Stake with New Equity Awards

Electromed's Chief Financial Officer, Bradley M. Nagel, reported an increase in his beneficial ownership through new restricted stock and stock option awards, alongside a tax-related share forfeiture.

Summary

• Bradley M. Nagel, Chief Financial Officer of Electromed, Inc. (ELMD), reported changes in his beneficial ownership.
• Mr. Nagel forfeited 562 shares of Common Stock at a price of $23.95 to satisfy tax withholding obligations related to previously vested restricted stock.
• He acquired 5,300 shares of Restricted Stock at a price of $0, which are scheduled to vest in three substantially equal annual installments on the first business days of September 2026, 2027, and 2028.
• Mr. Nagel also acquired 9,800 Employee Stock Options with an exercise price of $23.95, which are scheduled to vest and become exercisable in three substantially equal annual installments on the first business days of September 2026, 2027, and 2028.
• Following these transactions, Mr. Nagel beneficially owns 21,838 shares of Common Stock directly and 9,800 Employee Stock Options directly.

Sentiment

Score: 7

Explanation: The filing reflects routine executive compensation, which is generally a neutral to slightly positive event as it aligns management's interests with shareholders. The forfeiture for tax purposes is a standard, non-negative occurrence.

Positives

• The acquisition of 5,300 shares of restricted stock and 9,800 employee stock options increases the Chief Financial Officer's direct beneficial ownership and aligns his interests with long-term shareholder value.
• The new equity awards demonstrate continued commitment and incentivization of key management personnel.

Negatives

• A forfeiture of 562 shares of common stock occurred to cover tax withholding obligations, which is a standard practice for equity compensation.

Risks

• The value of the restricted stock and stock options is subject to the future market price fluctuations of Electromed, Inc.'s common stock.
• The vesting of these awards is contingent upon continued employment through the specified vesting dates, posing a risk of forfeiture if employment ceases.

Future Outlook

The future outlook for the Chief Financial Officer's compensation includes the vesting of restricted stock and stock options in substantially equal annual installments over the next three years, through September 2028, aligning his long-term incentives with the company's performance.

Industry Context

The equity awards granted to Electromed's Chief Financial Officer are consistent with standard executive compensation practices across the medical device and broader public company sectors, aiming to incentivize long-term performance and align management interests with shareholders.

Stakeholder Impact

• Shareholders: Increased alignment of the Chief Financial Officer's financial interests with the long-term performance of the company, potentially fostering more shareholder-centric decision-making.

Next Steps

• The restricted stock and employee stock options will vest in three substantially equal annual installments on the first business days of September 2026, 2027, and 2028.

Key Dates

Recommendation

This Form 4 details routine executive compensation awards and tax-related share forfeitures for Electromed's CFO. It does not provide new material information that would significantly alter the investment thesis for ELMD, thus a 'hold' recommendation is appropriate as it does not present a catalyst for a change in investment strategy.

Keywords

Electromed, ELMD, Form 4, Insider Transaction, Executive Compensation, Restricted Stock, Stock Options, CFO, Beneficial Ownership